EGFR and cancer: Moreover, in 2013, for patients diagnosed with head and neck types of cancer, Heukelom et al. analyzed the [89Zr]-cetuximab uptake in the view of chemoradiotherapy selection using either the antiepidermal growth factor receptor (EGFR) mAb cetuximab or cisplatin [159,160].